Case study: Leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines Importance to NHS Around 5.4 million people in the UK are currently receiving treatment for asthma and the N - Montelukast - Document - PDFSEARCH.IO

First Page	Meta Content
	Case study: Leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines Importance to NHS Around 5.4 million people in the UK are currently receiving treatment for asthma and the N Add to Reading List Document Date: 2014-01-20 10:28:34 Open Document File Size: 134,08 KB Share Result on Facebook Country United Kingdom / / Currency GBP / / Facility National Institute of Health Research Health Technology Assessment / University of Aberdeen / / MedicalCondition uncontrolled asthma / respiratory tract infections / mini asthma / initial asthma / daytime asthma / irreversible bronchoconstriction / asthma / / Movie Quality of life / / Organization Institute of Health Research Health Technology Assessment / National Institute of Health / University of Aberdeen / NHS / British Thoracic Society / / Person David Price / / Position Professor / controller / / URL www.hta.nihr.ac.uk / www.hta.ac.uk/1204 / / SocialTag Asthma Leukotriene Corticosteroid Montelukast Zafirlukast Pulmonology Leukotriene antagonists Respiratory therapy

Case study: Leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines Importance to NHS Around 5.4 million people in the UK are currently receiving treatment for asthma and the NAdd to Reading List